These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37236811)

  • 1. Performance of radiomics-based artificial intelligence systems in the diagnosis and prediction of treatment response and survival in esophageal cancer: a systematic review and meta-analysis of diagnostic accuracy.
    Menon N; Guidozzi N; Chidambaram S; Markar SR
    Dis Esophagus; 2023 May; 36(6):. PubMed ID: 37236811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
    Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R
    J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics diagnostic performance for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis.
    Ma D; Zhou T; Chen J; Chen J
    BMC Med Imaging; 2024 Jun; 24(1):144. PubMed ID: 38867143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics for the Prediction of Treatment Outcome and Survival in Patients With Colorectal Cancer: A Systematic Review.
    Staal FCR; van der Reijd DJ; Taghavi M; Lambregts DMJ; Beets-Tan RGH; Maas M
    Clin Colorectal Cancer; 2021 Mar; 20(1):52-71. PubMed ID: 33349519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
    Goense L; Meziani J; van Rossum PSN; Wessels FJ; Meijer GJ; Lam MGEH; van Hillegersberg R; Ruurda JP
    Nucl Med Commun; 2018 Jul; 39(7):645-651. PubMed ID: 29672463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies.
    Ruby L; Jayaprakasam VS; Fernandes MC; Paroder V
    Hematol Oncol Clin North Am; 2024 Jun; 38(3):711-730. PubMed ID: 38575457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
    Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
    Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI and
    Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
    Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Seol HY; Kim YS; Kim SJ
    Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Manafi-Farid R; Askari E; Shiri I; Pirich C; Asadi M; Khateri M; Zaidi H; Beheshti M
    Semin Nucl Med; 2022 Nov; 52(6):759-780. PubMed ID: 35717201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
    Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
    EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment CT and
    Rishi A; Zhang GG; Yuan Z; Sim AJ; Song EY; Moros EG; Tomaszewski MR; Latifi K; Pimiento JM; Fontaine JP; Mehta R; Harrison LB; Hoffe SE; Frakes JM
    J Med Imaging Radiat Oncol; 2021 Feb; 65(1):102-111. PubMed ID: 33258556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
    Alongi P; Rovera G; Stracuzzi F; Popescu CE; Minutoli F; Arnone G; Baldari S; Deandreis D; Caobelli F
    Curr Med Imaging; 2023; 19(8):832-843. PubMed ID: 36703586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysis.
    Han S; Kim YJ; Woo S; Suh CH; Lee JJ
    Clin Nucl Med; 2018 Dec; 43(12):887-894. PubMed ID: 30300200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
    Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
    Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects.
    Alabi RO; Elmusrati M; Leivo I; Almangush A; Mäkitie AA
    Int J Med Inform; 2024 Aug; 188():105464. PubMed ID: 38728812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.